Home / Markets / Stock Market News / Strong profit growth keeps brokerages positive on Torrent Pharma

Strong profit growth keeps brokerages positive on Torrent Pharma

Led by an 18% y-o-y growth in the domestic formulations segment, which accounts for over half its overall revenues, the company posted 16% growth at a consolidated level

Premium

Torrent Pharmaceuticals

Ram Prasad Sahu Mumbai

3 min read Last Updated : Oct 26 2023 | 11:03 PM IST

Listen to This Article

Even as the broader markets were under pressure, the stock of Torrent Pharmaceuticals was down 1.05 per cent on Thursday.

This was on expectation that steady sales growth momentum in core markets such as India and Brazil and recovery in the US market coupled with margin expansion will drive strong earnings growth over the next couple of years.

Brokerages are working with the net profit growth of 28-34 per cent annually over the FY23-25 period.

Led by an 18 per cent year-on-year (Y-o-Y) growth in the domestic formulations segment which accounts for over half its overall revenues, the company posted

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in